Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hannah R. Spiegl
Impact of MYCN Status on Response of High-Risk Neuroblastoma to Neoadjuvant Chemotherapy
Journal of Pediatric Surgery
Medicine
Child Health
Surgery
Pediatrics
Perinatology
Related publications
The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-Risk Neuroblastoma Independent of MYCN Status
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
MYCN Controls an Alternative RNA Splicing Program in High-Risk Metastatic Neuroblastoma
Cancer Letters
Cancer Research
Oncology
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Value of TP53 Status for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis
PLoS ONE
Multidisciplinary
Select BCL-2 Antagonism Restores Chemotherapy Sensitivity in High-Risk Neuroblastoma
BMC Cancer
Cancer Research
Oncology
Genetics
Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients With Colorectal Liver Metastases
Annals of Surgical Oncology
Oncology
Surgery
Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
Journal of Medical – Clinical Research & Reviews
Molecular Biomarkers to Predict Response to Neoadjuvant Chemotherapy for Bladder Cancer
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
Epigenetic Regulation of the Neuroblastoma Genes, Arid3b and Mycn
Oncogene
Cancer Research
Genetics
Molecular Biology